Drug target identification connects a disease mechanism with a candidate intervention point, such as a protein, gene or pathway. Researchers combine biological knowledge, patient data and experiments to judge whether changing that target could improve an outcome.
Choosing the wrong target can make excellent molecule design irrelevant. Models can help integrate evidence and rank candidates, but causal relevance and behavior in a complex human organism require experimental and clinical validation.
ELI5
Drug target identification finds a molecule or biological process that a treatment could change to improve a disease. A target might be a protein, gene or pathway connected to the disease mechanism.
For example, an AI system can combine research and patient data to rank proteins that may influence a condition. Laboratory and clinical evidence must then show that changing the target has the intended effect without unacceptable harm.
Why is target identification a bottleneck?
A plausible target may not cause the disease process or may have unacceptable effects elsewhere, and those relationships can be difficult to establish from limited data.
Can AI choose a drug target from scientific text alone?
Text can support hypothesis generation, but experimental and clinical data are needed to test causal biology and relevance to patients.
